Cargando…

Antimicrobial Chemotherapy for Recalcitrant Severe Human Periodontitis

This study evaluated a combined systemic and topical anti-infective periodontal treatment of 35 adults who had experienced ongoing periodontal breakdown following conventional surgical periodontics. The prescribed anti-infective therapy, based on microbiological testing, consisted of a single course...

Descripción completa

Detalles Bibliográficos
Autores principales: Rams, Thomas E., Slots, Jørgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951977/
https://www.ncbi.nlm.nih.gov/pubmed/36830176
http://dx.doi.org/10.3390/antibiotics12020265
_version_ 1784893514810654720
author Rams, Thomas E.
Slots, Jørgen
author_facet Rams, Thomas E.
Slots, Jørgen
author_sort Rams, Thomas E.
collection PubMed
description This study evaluated a combined systemic and topical anti-infective periodontal treatment of 35 adults who had experienced ongoing periodontal breakdown following conventional surgical periodontics. The prescribed anti-infective therapy, based on microbiological testing, consisted of a single course of metronidazole plus ciprofloxacin (23 patients), metronidazole plus amoxicillin/clavulanic acid (10 patients), and metronidazole plus ciprofloxacin followed by metronidazole plus amoxicillin/clavulanic acid (2 patients). In addition, the study patients received 0.1% povidone-iodine subgingival disinfection during non-surgical root debridement and daily patient administered oral irrigation with 0.1% sodium hypochlorite. At 1 and 5 years post-treatment, all study patients showed gains in clinical periodontal attachment with no further attachment loss, and significant decreases in pocket probing depth, bleeding on probing, and subgingival temperature. The greatest disease resolution occurred in patients who at baseline harbored predominantly major periodontal pathogens which post-antibiotics became non-detectable and substituted by non-periodontopathic viridans streptococci. The personalized and minimally invasive anti-infective treatment regimen described here controlled periodontitis disease activity and markedly improved the clinical and microbiological status of the refractory periodontitis patients.
format Online
Article
Text
id pubmed-9951977
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99519772023-02-25 Antimicrobial Chemotherapy for Recalcitrant Severe Human Periodontitis Rams, Thomas E. Slots, Jørgen Antibiotics (Basel) Article This study evaluated a combined systemic and topical anti-infective periodontal treatment of 35 adults who had experienced ongoing periodontal breakdown following conventional surgical periodontics. The prescribed anti-infective therapy, based on microbiological testing, consisted of a single course of metronidazole plus ciprofloxacin (23 patients), metronidazole plus amoxicillin/clavulanic acid (10 patients), and metronidazole plus ciprofloxacin followed by metronidazole plus amoxicillin/clavulanic acid (2 patients). In addition, the study patients received 0.1% povidone-iodine subgingival disinfection during non-surgical root debridement and daily patient administered oral irrigation with 0.1% sodium hypochlorite. At 1 and 5 years post-treatment, all study patients showed gains in clinical periodontal attachment with no further attachment loss, and significant decreases in pocket probing depth, bleeding on probing, and subgingival temperature. The greatest disease resolution occurred in patients who at baseline harbored predominantly major periodontal pathogens which post-antibiotics became non-detectable and substituted by non-periodontopathic viridans streptococci. The personalized and minimally invasive anti-infective treatment regimen described here controlled periodontitis disease activity and markedly improved the clinical and microbiological status of the refractory periodontitis patients. MDPI 2023-01-28 /pmc/articles/PMC9951977/ /pubmed/36830176 http://dx.doi.org/10.3390/antibiotics12020265 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Rams, Thomas E.
Slots, Jørgen
Antimicrobial Chemotherapy for Recalcitrant Severe Human Periodontitis
title Antimicrobial Chemotherapy for Recalcitrant Severe Human Periodontitis
title_full Antimicrobial Chemotherapy for Recalcitrant Severe Human Periodontitis
title_fullStr Antimicrobial Chemotherapy for Recalcitrant Severe Human Periodontitis
title_full_unstemmed Antimicrobial Chemotherapy for Recalcitrant Severe Human Periodontitis
title_short Antimicrobial Chemotherapy for Recalcitrant Severe Human Periodontitis
title_sort antimicrobial chemotherapy for recalcitrant severe human periodontitis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951977/
https://www.ncbi.nlm.nih.gov/pubmed/36830176
http://dx.doi.org/10.3390/antibiotics12020265
work_keys_str_mv AT ramsthomase antimicrobialchemotherapyforrecalcitrantseverehumanperiodontitis
AT slotsjørgen antimicrobialchemotherapyforrecalcitrantseverehumanperiodontitis